National Framework Agreement for the Homecare Delivery Service of licensed products for use in England and Wales for the treatment of bleeding disorders including recombinants and plasma derived products. Framework Duration - the framework duration is from 1.7.2014 to 30.6.2016, with two options to extend by up to 24 months.